Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Infliximab |
Trade Name | Remicade |
Synonyms | Avakine|cA2|Remsima |
Drug Descriptions |
Remicade (infliximab) is a monoclonal antibody that targets tumor necrosis factor alpha (TNF-alpha), potentially resulting in increased or decreased apoptosis (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | 170277-31-3 |
NCIT ID | C1789 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Infliximab | Infliximab | 0 | 0 |
Infliximab + Pembrolizumab | Infliximab Pembrolizumab | 0 | 1 |